FdaApplication
ANDA 217591
Identifiers
- fda_app_no: ANDA217591
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2025-11-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DALBAVANCIN HYDROCHLORIDE | DALBAVANCIN HYDROCHLORIDE | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product